Last week, our CEO Joanna Wiecek and the Head of R&D at GutSee Paulina Bartasun had the pleasure of pitching GutSee Health at the UK-Swiss University Showcase and Reception, hosted at the Swiss Embassy in London. It was an honor to present our work following the...
This week our CEO Jonna pitched GutSee Health at the London Demo Day 2025. Hosted by UCL Innovation & Enterprise at the UCL Institute of Education, the event brought together the most promising startups from London’s leading universities, showcasing the next...
We were pleased to take part in the recent European Defense Tech Hub demo day, where our CFO Cezary Wereszko pitched PhageX by GutSee Health. It was a fantastic opportunity to share both our progress and our plans for the project with an audience of innovators,...
Following the PhageX team’s win at the European Defense Tech Hackathon, our project has been gaining exciting recognition across Europe. PhageX, designed to harness biotechnology for critical field applications, captured the attention of the jury for its innovative...
GutSee CEO Joanna Wiecek and her team were awarded first place at the European Defense Tech Hackathon in Warsaw, Poland. PhageX team focused on addressing the problem of antibiotic-resistant infections on the battlefield using phages - viruses which target and kill...
Dr. Andrew Poullis at St George's University and GutSee Health are combining their expertise to explore how a disrupted microbiome contributes to gut disorders. GutSee's first clinical study will recruit 50 patients with Irritable Bowel Syndrome and Inflammatory Bowel...
Dr. Joanna Wiecek, CEO and co-founder of GutSee Health, was featured in an exciting new production by the renowned director Arman Alizad, exploring groundbreaking technologies shaping the future of human health. The series, 7 Kuolemansyntiä, recently won the...
GutSee Health, co-founded by Dr. Joanna Wiecek, a leading expert in microbiome research, has just secured initial venture capital investment to revolutionise the treatment of Irritable Bowel Syndrome and Inflammatory Bowel Disease. With this funding, the company is...